Roche Backs Full-Year View as First-Half Sales Rise
Roche Holding ROP 0.00%increase; up pointing triangle backed its full-year guidance as its pharmaceuticals division helped drive a…
Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation
Novartis Pharma AG – Proposed acquisition strengthens Novartis immunology strategy in food allergy and other IgE-driven diseases – Lead…
Something of a shopping spree: Novartis to acquire US-based Excellergy for up to $2bn
The life of a biotech company can be short—and if it appears on the fast-spinning takeover radar of…
Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation
– Proposed acquisition strengthens Novartis immunology strategy in food allergy and other IgE-driven diseases – Lead asset…